Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Long-lasting effects on memory impairment of M2 antagonist treatment in rats

Dec. 2, 1997

Potent antiamnesia activity reported for AChE inhibitor DHED

Dec. 2, 1997

Anticonvulsant activity of retigabine established in preclinical model

Dec. 2, 1997

Takeda's PAF antagonist evaluated in preclinical model of asthma

Dec. 2, 1997

Phase I/II clinical trial of gene therapy for melanoma

Dec. 1, 1997

IL-2 gene therapy for metastatic solid tumors: phase I results

Dec. 1, 1997

New anesthetic agent in phase I at Synthelabo

Dec. 1, 1997

Dual-action compound YM-158 shows potential for asthma

Dec. 1, 1997

Preclinical results reported for Novartis' PDE IV inhibitor

Dec. 1, 1997

Esteve presents new calcium antagonists with potential as neuroprotectants

Dec. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...